AT
Arden Trust Portfolio holdings
AUM
$716M
1-Year Return
17.63%
This Quarter Return
-0.45%
1 Year Return
+17.63%
3 Year Return
+22.55%
5 Year Return
+83.07%
10 Year Return
+181.13%
AUM
$727M
AUM Growth
-$5.5M
(-0.75%)
Cap. Flow
+$173K
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
347
New
28
Increased
60
Reduced
208
Closed
13
Top Buys
| 1 |
AT&T
T
|
$5.06M |
| 2 |
AGN
Allergan plc
AGN
|
$2.14M |
| 3 |
TE Connectivity
TEL
|
$1.85M |
| 4 |
WFT
Weatherford International plc
WFT
|
$1.7M |
| 5 |
AbbVie
ABBV
|
$1.47M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$4.23M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
$2.62M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$1.41M |
| 4 |
Vanguard Total Bond Market
BND
|
$1.38M |
| 5 |
Rio Tinto
RIO
|
$1.07M |
Sector Composition
| 1 | Healthcare | 9.76% |
| 2 | Technology | 7.87% |
| 3 | Financials | 7.03% |
| 4 | Industrials | 6.37% |
| 5 | Energy | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
BP
BP
$87.4B
| $973K | 0.13% |
27,078
+623
| +2% | +$22.4K |
|
152
Nike
NKE
$109B
| $956K | 0.13% |
21,420
-1,920
| -8% | -$85.7K |
|
|
XLNX
153
DELISTED
Xilinx Inc
XLNX
| $954K | 0.13% |
22,529
+3,627
| +19% | +$154K |
|
154
Vanguard S&P 500 ETF
VOO
$728B
| $941K | 0.13% |
+5,212
| New | +$941K |
|
155
SAP
SAP
$313B
| $937K | 0.13% |
12,984
-550
| -4% | -$39.7K |
|
156
Vertex Pharmaceuticals
VRTX
$102B
| $937K | 0.13% |
8,338
-267
| -3% | -$30K |
|
157
Northrop Grumman
NOC
$83.2B
| $916K | 0.13% |
6,949
-761
| -10% | -$100K |
|
158
ORIX
IX
$29.3B
| $913K | 0.13% |
66,140
-2,355
| -3% | -$32.5K |
|
159
Automatic Data Processing
ADP
$120B
| $901K | 0.12% |
12,349
-43
| -0.3% | -$3.14K |
|
160
Check Point Software Technologies
CHKP
$20.7B
| $895K | 0.12% |
+12,936
| New | +$895K |
|
161
TEGNA Inc
TGNA
$3.38B
| $893K | 0.12% |
57,538
| – | – |
|
162
Emerson Electric
EMR
$74.6B
| $884K | 0.12% |
14,125
+200
| +1% | +$12.5K |
|
163
Teva Pharmaceuticals
TEVA
$21.7B
| $879K | 0.12% |
16,345
-648
| -4% | -$34.8K |
|
164
CME Group
CME
$94.4B
| $878K | 0.12% |
10,983
-426
| -4% | -$34.1K |
|
|
PLL
165
DELISTED
PALL CORP
PLL
| $877K | 0.12% |
10,482
-61
| -0.6% | -$5.1K |
|
166
Cencora
COR
$56.7B
| $872K | 0.12% |
11,281
-77
| -0.7% | -$5.95K |
|
167
Norfolk Southern
NSC
$62.3B
| $864K | 0.12% |
7,745
-30
| -0.4% | -$3.35K |
|
168
iShares Floating Rate Bond ETF
FLOT
$9.12B
| $863K | 0.12% |
16,984
| – | – |
|
169
AstraZeneca
AZN
$253B
| $862K | 0.12% |
24,116
-726
| -3% | -$26K |
|
170
Fluor
FLR
$6.72B
| $853K | 0.12% |
12,771
-1,671
| -12% | -$112K |
|
171
Unilever
UL
$158B
| $844K | 0.12% |
20,155
+3,071
| +18% | +$129K |
|
172
Lockheed Martin
LMT
$108B
| $843K | 0.12% |
4,612
-312
| -6% | -$57K |
|
173
Barclays
BCS
$69.1B
| $841K | 0.12% |
61,026
-1,204
| -2% | -$16.6K |
|
174
Aflac
AFL
$57.2B
| $822K | 0.11% |
28,232
-556
| -2% | -$16.2K |
|
175
Conagra Brands
CAG
$9.23B
| $787K | 0.11% |
30,623
-2,730
| -8% | -$70.2K |
|